Published in AIDS Weekly, March 30th, 2009
"The uptake of Tat was followed by an increase in MCPI (CCL2) immunoreactivity. Approximately 70% of neurons were able to survive transient or Continuous (7 days) Tat exposure. The surviving neurons did not contain bound/internalized Tat, but were able to interact with Tat...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.